- Home
- DYNX vs PRQR Comparison
DYNX vs PRQR Comparison
Compare DYNX & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYNX
- PRQR
- Stock Information
- Founded
- DYNX 2024
- PRQR 2012
- Country
- DYNX United States
- PRQR Netherlands
- Employees
- DYNX N/A
- PRQR N/A
- Industry
- DYNX
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- DYNX
- PRQR Health Care
- Exchange
- DYNX NYSE
- PRQR Nasdaq
- Market Cap
- DYNX 221.3M
- PRQR 179.1M
- IPO Year
- DYNX 2024
- PRQR 2014
- Fundamental
- Price
- DYNX $10.19
- PRQR $1.93
- Analyst Decision
- DYNX
- PRQR Strong Buy
- Analyst Count
- DYNX 0
- PRQR 7
- Target Price
- DYNX N/A
- PRQR $9.00
- AVG Volume (30 Days)
- DYNX 15.7K
- PRQR 288.1K
- Earning Date
- DYNX 01-01-0001
- PRQR 08-07-2025
- Dividend Yield
- DYNX N/A
- PRQR N/A
- EPS Growth
- DYNX N/A
- PRQR N/A
- EPS
- DYNX N/A
- PRQR N/A
- Revenue
- DYNX N/A
- PRQR $21,212,711.00
- Revenue This Year
- DYNX N/A
- PRQR N/A
- Revenue Next Year
- DYNX N/A
- PRQR N/A
- P/E Ratio
- DYNX N/A
- PRQR N/A
- Revenue Growth
- DYNX N/A
- PRQR 85.91
- 52 Week Low
- DYNX $9.78
- PRQR $1.07
- 52 Week High
- DYNX $10.48
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- DYNX N/A
- PRQR 60.77
- Support Level
- DYNX N/A
- PRQR $1.77
- Resistance Level
- DYNX N/A
- PRQR $2.03
- Average True Range (ATR)
- DYNX 0.00
- PRQR 0.10
- MACD
- DYNX 0.00
- PRQR 0.01
- Stochastic Oscillator
- DYNX 0.00
- PRQR 72.97
About DYNX DYNAMIX CORP
Dynamix Corp is a blank check company.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.